CADL
Price
$5.55
Change
+$0.28 (+5.31%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
304.12M
40 days until earnings call
CELC
Price
$50.60
Change
-$1.34 (-2.58%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
2.15B
51 days until earnings call
Interact to see
Advertisement

CADL vs CELC

Header iconCADL vs CELC Comparison
Open Charts CADL vs CELCBanner chart's image
Candel Therapeutics
Price$5.55
Change+$0.28 (+5.31%)
Volume$7.86K
Capitalization304.12M
Celcuity
Price$50.60
Change-$1.34 (-2.58%)
Volume$11.31K
Capitalization2.15B
CADL vs CELC Comparison Chart in %
Loading...
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CADL vs. CELC commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a StrongBuy and CELC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (CADL: $5.55 vs. CELC: $50.60)
Brand notoriety: CADL and CELC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 61% vs. CELC: 29%
Market capitalization -- CADL: $289.3M vs. CELC: $2.2B
CADL [@Biotechnology] is valued at $289.3M. CELC’s [@Biotechnology] market capitalization is $2.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileCELC’s FA Score has 1 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • CELC’s FA Score: 1 green, 4 red.
According to our system of comparison, CELC is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while CELC’s TA Score has 3 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 6 bearish.
  • CELC’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CELC is a better buy in the short-term than CADL.

Price Growth

CADL (@Biotechnology) experienced а +15.38% price change this week, while CELC (@Biotechnology) price change was -2.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

CADL is expected to report earnings on Nov 06, 2025.

CELC is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($2.15B) has a higher market cap than CADL($304M). CELC YTD gains are higher at: 286.555 vs. CADL (-36.060). CADL has higher annual earnings (EBITDA): -19.74M vs. CELC (-135.56M). CELC has more cash in the bank: 168M vs. CADL (101M). CADL has less debt than CELC: CADL (8.34M) vs CELC (99.4M). CADL (0) and CELC (0) have equivalent revenues.
CADLCELCCADL / CELC
Capitalization304M2.15B14%
EBITDA-19.74M-135.56M15%
Gain YTD-36.060286.555-13%
P/E RatioN/AN/A-
Revenue00-
Total Cash101M168M60%
Total Debt8.34M99.4M8%
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
25
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CADLCELC
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 5 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 23 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVLIX25.39N/A
N/A
JHancock Disciplined Value I
HSUTX69.98N/A
N/A
Rational Dynamic Brands Instl
AUUYX25.15N/A
N/A
AB Select US Equity Advisor
NDVIX17.83N/A
N/A
MFS New Discovery Value I
HFDFX19.49N/A
N/A
Hartford Schroders US MidCap Opps F

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with RPTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+5.31%
RPTX - CADL
44%
Loosely correlated
+1.20%
INKT - CADL
34%
Loosely correlated
+2.65%
INO - CADL
33%
Poorly correlated
+1.69%
CELC - CADL
32%
Poorly correlated
-2.58%
MRNA - CADL
31%
Poorly correlated
-0.45%
More

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been closely correlated with IMA. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if CELC jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-2.58%
IMA - CELC
84%
Closely correlated
-0.37%
NEVPF - CELC
61%
Loosely correlated
N/A
BEAM - CELC
45%
Loosely correlated
-0.48%
CLDX - CELC
44%
Loosely correlated
+3.52%
ABOS - CELC
43%
Loosely correlated
-3.04%
More